Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Coordinated nuclear and synaptic shuttling of afadin promotes spine plasticity and histone modifications.

The Journal of biological chemistry | 2014

The ability of a neuron to transduce extracellular signals into long lasting changes in neuronal morphology is central to its normal function. Increasing evidence shows that coordinated regulation of synaptic and nuclear signaling in response to NMDA receptor activation is crucial for long term memory, synaptic tagging, and epigenetic signaling. Although mechanisms have been proposed for synapse-to-nuclear communication, it is unclear how signaling is coordinated at both subcompartments. Here, we show that activation of NMDA receptors induces the bi-directional and concomitant shuttling of the scaffold protein afadin from the cytosol to the nucleus and synapses. Activity-dependent afadin nuclear translocation peaked 2 h post-stimulation, was independent of protein synthesis, and occurred concurrently with dendritic spine remodeling. Moreover, activity-dependent afadin nuclear translocation coincides with phosphorylation of histone H3 at serine 10 (H3S10p), a marker of epigenetic modification. Critically, blocking afadin nuclear accumulation attenuated activity-dependent dendritic spine remodeling and H3 phosphorylation. Collectively, these data support a novel model of neuronal nuclear signaling whereby dual-residency proteins undergo activity-dependent bi-directional shuttling from the cytosol to synapses and the nucleus, coordinately regulating dendritic spine remodeling and histone modifications.

Pubmed ID: 24567331 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Antibodies used in this publication

Associated grants

  • Agency: NINDS NIH HHS, United States
    Id: 1F31NS076201
  • Agency: NIMH NIH HHS, United States
    Id: R01 MH097216
  • Agency: Medical Research Council, United Kingdom
    Id: MR/L021064/1
  • Agency: NIDA NIH HHS, United States
    Id: DA013141-11A1
  • Agency: NIDA NIH HHS, United States
    Id: R01 DA013141
  • Agency: NIMH NIH HHS, United States
    Id: 1F31MH087043
  • Agency: NIMH NIH HHS, United States
    Id: F31 MH087043
  • Agency: NIMH NIH HHS, United States
    Id: F31 MH085362
  • Agency: NIMH NIH HHS, United States
    Id: MH097216
  • Agency: NIMH NIH HHS, United States
    Id: 1F31MH085362
  • Agency: NINDS NIH HHS, United States
    Id: F31 NS076201
  • Agency: NIMH NIH HHS, United States
    Id: MH071316
  • Agency: NIMH NIH HHS, United States
    Id: R01 MH071316

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


c-myc (antibody)

RRID:AB_2266850

This monoclonal targets MYC

View all literature mentions